BioAtla

0 followers


BioAtla develops safer, more effective drugs for cancer using a proprietary next-generation antibody discovery and evolution platform.

Employees

51-200

Links

Org chart

Jay Short
Chairman, Chief Executive Officer & Cofounder

Jay Short

Collapse
Richard Waldron
Chief Financial Officer
Eric Sievers
Chief Medical Officer
Cathy Chang
SVP, Research & Development
Monica Sullivan
SVP, Intellectual Property & Contracts
Sheri Lydick
Chief Commercial Officer
Susie Melody
SVP, Human Resources
Gerhard Frey
SVP, Technology Development